期刊文献+

吡柔比星联合干扰素抑制大鼠膀胱癌生长的机制 被引量:2

The Suppression Mechanism of the Growth of Bladder Cancer on Pirarubicin Combined with Interferon
下载PDF
导出
摘要 目的探讨吡柔比星联合干扰素α-2b膀胱灌注对大鼠膀胱肿瘤生长的抑制作用和机制。方法 80只雌性Wistar大鼠随机分为对照组、吡柔比星组、干扰素组和联合用药组,每组20只。制作N-甲基亚硝基脲诱导大鼠原位膀胱癌模型,于第8周分别以生理盐水、吡柔比星、重组干扰素α-2b和吡柔比星+重组干扰素α-2b连续膀胱灌注,每周1次,共6次。第8和14周进行病理观察,第14周测量膀胱质量,免疫组织化学法检测微血管密度(MVD),流式细胞仪测凋亡指数(AI)。结果第8周时,各组大鼠膀胱黏膜呈不典型增生和移行细胞癌Ⅰ级。第14周时,可见菜花状、多发膀胱肿瘤并侵入肌层。吡柔比星组和联合用药组大鼠膀胱质量小于对照组(P<0.01),联合用药组大鼠膀胱质量小于吡柔比星组(P<0.05),联合用药组MVD小于干扰素组(P<0.01),联合用药组大鼠的AI高于其他3组(P<0.01),吡柔比星组和干扰素组的AI大于对照组(P分别<0.01和0.05)。结论吡柔比星联合干扰素α-2b膀胱灌注可抑制大鼠膀胱肿瘤生长,其机制与二者协同作用抑制肿瘤血管生长和诱导肿瘤细胞凋亡有关。 Objective To observe the suppression mechanism of the growth of bladder cancer on pirarubicin combined with interferon.Methods 80 female Wistar rats were randomly divided into four groups:control group,pirarubicin group,interferon group and combination group.Establish N-nitrosourea Induction model of rat orthotopic bladder cancer,four groups were respectively received a total of six times(every week) intravesical instillation of physiologic saline,pirarubicin,interferon(α-2b) and combination drugs from the eighth week,Pathological observation was done at the 8th week and the 14th week.The weights of bladders,microvessel densities(MVD) and apoptotic indexes(AI) were investigated.Results The mucosal of bladder was showed dysplasia and transitional cell I in both groups at the 8th week.Muscle layer of bladder could be seen cauliflower-like,multiple bladder tumors at the 14th week.The weight of bladder in pirarubicin group and combination group were less than those of control group(P 0.01),the latter was less than that of pirarubicin group(P 0.05).The MVD of combination group was less than that of interferon group(P 0.01),and the AI of it was higher than that of other three groups(P 0.01).The AI of pirarubicin group and interferon group were higher than those of control group(P 0.01,P 0.05).Conclusion Intravesical instillation of pirarubicin and interferon could inhibit the growth of bladder tumour by restraining angiogenesis and accelerating apoptosis in rats.
出处 《中国医科大学学报》 CAS CSCD 北大核心 2011年第9期812-815,共4页 Journal of China Medical University
基金 辽宁省科学技术计划项目(2010225034)
关键词 膀胱肿瘤 吡柔比星 干扰素 凋亡 微血管密度 大鼠 bladder tumor pirarubicin interferon apoptosis microvessel densities rats
  • 相关文献

参考文献10

  • 1Sylvester R J, der Meijden AP, Oosterlinck W, et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables:a combined analysis of 2596 patients from seven EORTC trials [ J ]. Eur Urol, 2006,49 (3) : 466- 475.
  • 2Brausi M, Collette L, Kurth K, et al. Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies[J]. Eur Urol,2002,41 (5):523-531.
  • 3Shah SC ,Kusiak A,O' Donnell MA. Patient-recognition data-mining model for BCG-plus interferon immunotherapy bladder cancer treatment [ J ]. Comput Biol Med, 2006,36(6) : 634-655.
  • 4Rosevear HM, Lightfoot A J, Nepple KG, et al. Usefulness of the Spanish Urological Club for Oncological Treatment scoring model to predict nonmuscle invasive bladder cancer recurrence in patients treated with intravesical bacillus Calmette-Guerin plus interferon-alpha [J ].J Urol,2011,185(1):67-71.
  • 5高建国,田涛,宋亚林,董中意,杨晓峰.围手术期大剂量吡柔比星膀胱灌注预防膀胱癌复发的临床观察[J].中华外科杂志,2010,48(21):1650-1652. 被引量:6
  • 6Qian L, Ding H, Zhou J, et al. Intravesieal N-(4-hydroxyphenyl ) retinamide and adriamyein induees apoptosis in bladder cancer [J]. Front Biosei, 2006,11 (9) : 2045-2051.
  • 7李清,徐涛,王晓峰.吡柔比星膀胱内灌注预防非肌层浸润性膀胱尿路上皮癌复发的机制[J].中华肿瘤杂志,2009,31(12):904-907. 被引量:29
  • 8Yao JC,Phan A, Hoff PM, et al. Targeting vascular endothelial growth factor in advanced carcinoid tumor:a random assignment phase II study of depot octreotide with bevacizumab and pegylated interferon alpha-2b[ J ]. J Clin Oncol,2008,26(8) : 1316-1323.
  • 9Caraccio N, Cuccato S, Pratesi F, et al. Effect of type I interferon (s) on cell viability and apoptosis in primary human thyrocyte cultures [J]. Thyroid, 2009,19(2) : 149-155.
  • 10Duchek M, Johansson R, Jahnson S,et al. Bacillus Calmette-Guerin is superior to a combination of epirubicin and intefferon-alpha2b in the intravesical treatment of patients with stage T1 urinary bladder cancer. A prospective,randomized,Nordic study [J]. Eur Urol, 2010,57( 1 ) :25-31.

二级参考文献18

  • 1吴忠标,林国兵,陈柏君,吴忠明,戎瑞明.不同剂量表柔比星膀胱灌注预防浅表性膀胱癌复发的疗效与安全性[J].中华肿瘤杂志,2005,27(8):507-509. 被引量:17
  • 2Waters WB. Invasive bladder cancer: where do we go from here? J Urol, 1996, 155:1910-1911.
  • 3Tolley DA, Parrrkar MK, Grigor KM, et al. The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: a further report with 7 years of follow up. J Urol, 1996, 155 : 1233-1238.
  • 4Sylvester RJ, van der Meijden AP, Osterlinck W, et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol, 2006, 49:466- 477.
  • 5Okamura K, Ono Y, Kinukawa S, et al. Randomized study of single early instillation of ( 2" R )4'-O-tetrahydropyranyl- doxorubicin for a single superficial bladder carcinoma. Cancer, 2002, 94:2363-2368.
  • 6Akaza H, Kurth KH, Williams R, et al. Intravesical chemotherapy and immunotherapy for superficial tumour: Basic mechanism of action and future direction. Urol Oncol, 1998, 4 : 121-129.
  • 7Gasion JP, Cruz JF. Improving efficacy of intravesical chemotherapy. Eur Urol, 2006, 50:225-234.
  • 8Sonpavde G, Petrylak DP. Perioperative chemotherapy for bladder cancer. Crit Rev Oncol Hematol, 2006, 57:133-144.
  • 9Takahashi T, Kushiro A, Nomoto K, et al. Antitumor effects of the intravesical instillation of heat killed cells of the Lactobacillus casei strain Shirota on the murine orthotopic bladder tumor MBT- 2. J Urol, 2001, 166:2506-2511.
  • 10Iguchi H, Teranishi Y, Tone 14 Vesical tissue concentration of pirarubicin after intravesical instillation in rats. Basic Clin Report, 1994, 28: 21-24.

共引文献32

同被引文献23

引证文献2

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部